Kinaset Therapeutics, Inc. — Form D
Kinaset Therapeutics, Inc. of MEDFIELD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-17. The offering totals $40.0M, of which $1.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-08-17
- Form: D
- Accession: 0001821223-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $40.0M
- Amount sold: $1.5M
- Remaining: $38.5M
- Minimum investment: $375K
- Investors: 3
- Date of first sale: 2020-07-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-373382
Issuer
- Name: Kinaset Therapeutics, Inc.
- CIK: 0001821223
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 10 KNOLLWOOD ROAD, MEDFIELD, MA, 02052
- Phone: (508) 858-5810
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Kevin Bitterman | Director | Cambridge, MA |
| Robert Clarke | Director | Dover, DE |
| Robert Clarke | Executive Officer | Dover, DE |
| Robert Clarke | Promoter | Dover, DE |
| Tom King | Director | Medfield, MA |
| Jamil Beg | Director | Cambridge, MA |
| Bram Vanparys | Director | Medfield, MA |
| Frazer Morgan | Executive Officer | Medfield, MA |
| Frazer Morgan | Promoter | Medfield, MA |
| Roger Heerman | Executive Officer | Medfield, MA |
| Roger Heerman | Promoter | Medfield, MA |
Other filings by this issuer (2)
More